Source: Health Products and Food Branch (CA) Revision Year: 2014
LOXAPAC IM – loxapine hydrochloride injection 50 mg/mL.
| Route of Administration | Dosage Form/Strength | Nonmedicinal Ingredients |
|---|---|---|
| Intramuscular | Solution for injection, 50 mg/mL | Polysorbate 80, propylene glycol, hydrochloric acid and/or sodium hydroxide to adjust pH and water for injection. |
Each mL contains: loxapine hydrochloride equivalent to 50 mg of loxapine, polysorbate 80 5% w/v, propylene glycol 70% v/v, hydrochloric acid and/or sodium hydroxide to adjust pH to approximately 6.0 and water for injection.
LOXAPAC IM (loxapine hydrochloride injection) is available in 1 mL sterile ampoules, boxes of 10.
| Marketing Informations | Authorization Dates |
|---|---|
|
Authorization holder:
|
| Drug | Countries | |
|---|---|---|
| LOXAPAC | Canada, France |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
